Page last updated: 2024-08-21

indazoles and Neuroectodermal Tumors, Primitive

indazoles has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bando, M; Endo, S; Hagiwara, K; Kurosaki, A; Mato, N; Niki, T; Onuki, T; Sakamoto, N; Takigami, A; Tetsuka, K; Yamasawa, H	1

Other Studies

1 other study(ies) available for indazoles and Neuroectodermal Tumors, Primitive

Article	Year
Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung. Internal medicine (Tokyo, Japan), 2019, May-01, Volume: 58, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fatal Outcome; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Pneumonectomy; Progression-Free Survival; Pyrimidines; Sarcoma, Ewing; Sulfonamides; Treatment Outcome	2019

Article

Year

Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung.

Internal medicine (Tokyo, Japan), 2019, May-01, Volume: 58, Issue:9

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fatal Outcome; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Pneumonectomy; Progression-Free Survival; Pyrimidines; Sarcoma, Ewing; Sulfonamides; Treatment Outcome

2019